Showing results (151-160 of 463) with videos related to
Sort By:
Pageof 47
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1995
Azithromycin does not increase plasma concentrations of oral midazolamJ T Backman, K T Olkkola, P J NeuvonenClinical Pharmacology and Therapeutics|April 1, 1997
Itraconazole greatly increases plasma concentrations and effects of felodipineK M Jalava, K T Olkkola, P J NeuvonenBritish Journal of Anaesthesia|January 30, 1999
The CYP 3A4 inhibitor itraconazole has no effect on the pharmacokinetics of i.v. fentanylV J Palkama, P J Neuvonen, K T OlkkolaClinical Pharmacology and Therapeutics|January 1, 1996
Rifampin drastically reduces plasma concentrations and effects of oral midazolamJ T Backman, K T Olkkola, P J NeuvonenInternational Journal of Clinical Pharmacology and Therapeutics|September 3, 1998
The CYP3A4 inhibitor intraconazole does not affect the pharmacokinetics of a new calcium-sensitizing drug levosimendanS Antila, T Honkanen, L Lehtonen, et al.Archives of Disease in Childhood. Fetal and Neonatal Edition|June 23, 2001
Ketamine for procedural pain relief in newborn infantsE Saarenmaa, P J Neuvonen, P Huttunen, et al.Arzneimittel-Forschung|March 1, 1975
Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA)H Vapaatalo, D Onken, P J Neuvonen, et al.Pharmacology & Toxicology|March 6, 1999
Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspironeK T Kivistö, T S Lamberg, P J NeuvonenBritish Journal of Clinical Pharmacology|October 1, 1991
The bioavailability of sustained release nicotinic acid formulationsP J Neuvonen, L Roivas, K Laine, et al.British Journal of Anaesthesia|February 16, 2000
Effect of itraconazole on the pharmacokinetics of bupivacaine enantiomers in healthy volunteersV J Palkama, P J Neuvonen, K T OlkkolaPageof 47